Insider · CIK 0001220297

ALVAREZ CESAR L

Reports to the SEC for 6 companies · GERMANTOWN, MD

sec.gov

Transactions

Companies

Filings

CIK

0001220297

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-13	PGENPRECIGEN, INC.M Exercise/Conversion	Director	MExercise/Conversion	+71.8K sh	—	—	782,909
2026-03-13	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−71.8K sh	—	—	0
2026-03-10	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	Director	AAward	+35.6K sh	—	—	35,612
2026-03-10	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	Director	AAward	+41.1K sh	—	—	41,073
2026-03-10	PGENPRECIGEN, INC.A Award	Director	AAward	+17.8K sh	$3.51	+$62.5K	711,070
2025-03-14	PGENPRECIGEN, INC.M Exercise/Conversion	Director	MExercise/Conversion	+87.4K sh	—	—	693,264
2025-03-14	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−87.4K sh	—	—	0
2025-03-13	PGENPRECIGEN, INC.A Award	Director	AAward	+35.9K sh	$1.74	+$62.5K	605,852
2025-03-13	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	Director	AAward	+71.8K sh	—	—	71,839
2025-03-13	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	Director	AAward	+83.5K sh	—	—	83,517
2025-03-05	WSOWATSCO INCS Sale	Director	SSale	−679 sh	$498.92	−$339K	0
2025-03-05	WSOWATSCO INCM Exercise/Conversion	Director	MExercise/Conversion	+1,421 sh	$175.07	+$249K	0
2025-03-05	WSOWATSCO INC · Stock Option (right to buy)A Award	Director	AAward	+1,500 sh	$501.67	+$753K	1,500
2025-03-05	WSOWATSCO INCM Exercise/Conversion	Director	MExercise/Conversion	+679 sh	$175.07	+$119K	0
2025-03-05	WSOWATSCO INCM Exercise/Conversion	Director	MExercise/Conversion	+400 sh	$175.07	+$70K	400
2025-03-05	WSOWATSCO INCS Sale	Director	SSale	−1,421 sh	$500.00	−$711K	0
2025-03-05	WSOWATSCO INC · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	$175.07	−$438K	0
2024-03-14	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	Director	AAward	+102K sh	—	—	101,626
2024-03-14	PGENPRECIGEN, INC.A Award	Director	AAward	+43.7K sh	$1.43	+$62.5K	569,933
2024-03-14	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	Director	AAward	+87.4K sh	—	—	87,412
2024-03-09	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−107K sh	—	—	0
2024-03-09	PGENPRECIGEN, INC.M Exercise/Conversion	Director	MExercise/Conversion	+107K sh	—	—	526,227
2023-12-12	WSOWATSCO INC · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	$160.69	−$803K	0
2023-12-12	WSOWATSCO INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$160.69	+$803K	0
2023-12-12	WSOWATSCO INCS Sale	Director	SSale	−5,000 sh	$412.34	−$2.06M	0
2023-05-22	WSOWATSCO INCM Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	$185.12	+$740K	0
2023-05-22	WSOWATSCO INCS Sale	Director	SSale	−4,000 sh	$332.64	−$1.33M	0
2023-05-22	WSOWATSCO INC · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	$185.12	−$740K	0
2023-03-09	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	Director	AAward	+107K sh	—	—	106,837
2023-03-09	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	Director	AAward	+125K sh	—	—	125,489
2023-03-09	PGENPRECIGEN, INC.A Award	Director	AAward	+53.4K sh	$1.17	+$62.5K	419,390
2023-02-22	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−61.6K sh	—	—	0
2023-02-22	PGENPRECIGEN, INC.M Exercise/Conversion	Director	MExercise/Conversion	+61.6K sh	—	—	365,972
2022-05-27	WSOWATSCO INCS Sale	Director	SSale	−900 sh	$255.29	−$230K	0
2022-05-27	WSOWATSCO INC · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	$143.86	−$575K	0
2022-05-27	WSOWATSCO INCS Sale	Director	SSale	−3,100 sh	$253.05	−$784K	0
2022-05-27	WSOWATSCO INCM Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	$143.86	+$575K	0
2022-03-25	PGENPRECIGEN, INC.M Exercise/Conversion	Director	MExercise/Conversion	+16.2K sh	—	—	304,396
2022-03-25	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−16.2K sh	—	—	0
2022-02-22	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	Director	AAward	+83.2K sh	—	—	83,189
2022-02-22	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	Director	AAward	+61.6K sh	—	—	61,576
2022-02-22	PGENPRECIGEN, INC.A Award	Director	AAward	+30.8K sh	$2.03	+$62.5K	288,184
2021-03-25	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	Director	AAward	+16.2K sh	—	—	16,212
2021-03-25	PGENPRECIGEN, INC.A Award	Director	AAward	+8,106 sh	$7.71	+$62.5K	257,396
2021-03-25	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	Director	AAward	+22.1K sh	—	—	22,107
2021-03-13	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−62.2K sh	—	—	0
2021-03-13	PGENPRECIGEN, INC.M Exercise/Conversion	Director	MExercise/Conversion	+62.2K sh	—	—	249,290
2021-03-03	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,968 sh	—	—	0
2021-03-03	PGENPRECIGEN, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,968 sh	$5.69	+$16.9K	187,101
2020-06-23	PGENPRECIGEN, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,968 sh	$3.17	+$9,408.56	184,133

Recent filings

Accepted (ET)
Mar 164
ALVAREZ CESAR L0000950103-26-003836
SEC(opens sec.gov)
Mar 124
ALVAREZ CESAR L0000950103-26-003682
SEC(opens sec.gov)
Mar 174
ALVAREZ CESAR L0000950103-25-003514
SEC(opens sec.gov)
Mar 74
ALVAREZ CESAR L0000950170-25-035531
SEC(opens sec.gov)
Mar 184
ALVAREZ CESAR L0000950103-24-003953
SEC(opens sec.gov)

Companies

Address

20374 SENECA MEADOWS PARKWAY

GERMANTOWN, MD, 20876